Ilaris (canakinumab)

**Product type:** Human Prescription Drug

**Active ingredient:** CANAKINUMAB

**Strength:** 150 mg/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Novartis Pharmaceuticals Corporation

**Marketing category:** BLA (BLA125319)